Bioretec Receives CMS Pass-Through Payment for the US Market →

Home
Products
Company
News
Contact

Activa
RemeOs™
Investors

Clinical and Technical Publications

Nothing Found

It seems we can’t find what you’re looking for. Perhaps searching can help.

Search

Recent Posts

Bioretec Ltd publishes an exemption document relating to its rights issue
Inside information: Bioretec Ltd’s Board of Directors resolved on a rights issue of up to approximately EUR 14.8 million and publishes the terms and conditions of the rights issue
Bioretec Ltd’s resolutions of the Extraordinary General Meeting
The Finnish Financial Supervisory Authority has granted Stephen Industries Inc Oy and Kustaa Poutiainen a permanent exemption from the obligation to launch a mandatory public takeover bid
Change to the publication date of Business Review: Bioretec publishes January-March 2026 Business Review on 15 May 2026

Recent Comments

No comments to show.

Archives

April 2026
March 2026
February 2026
January 2026
December 2025
November 2025
October 2025
September 2025
August 2025
July 2025
June 2025
May 2025
April 2025
March 2025
February 2025
January 2025
December 2024
November 2024
October 2024
September 2024
August 2024
June 2024
May 2024
April 2024
March 2024
February 2024
January 2024
December 2023
November 2023

Categories

Press Release
Clinical and Technical Publications

Better healing – better life

Products

Product overviewActivaRemeOs

About Bioretec

CompanyCareersNews & EventsStoriesSales & Marketing Hub

Financials

Connect

ContactDistributors

Newsletter

Sign up to receive updates on Bioretec’s webinars, events, publications, and products. By subscribing, you agree to our privacy policy.

© Bioretec. All rights reserved. Specifications are subject to change without notice.

Cookies